SCHEMBL6173852

SCHEMBL6173852

CCOC(=O)c1cc(C(C)C2(C(C)c3ccnc(C(=O)OCC)c3)NC(=O)N(c3ccc(S(=O)(=O)C(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.37
MAPT P10636 1/20 0.36
CHRNA7 P36544 2/20 0.35
CA9 Q16790 3/20 0.34
MLYCD O95822 2/20 0.34
AR P10275 1/20 0.34
TRPV3 Q8NET8 3/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172914 0.88 IGF1R (0.38) IGF1RARTRPV3KMT2AHRH4
SCHEMBL6174541 0.87 SLC5A1 (0.40) MAPTMLYCD
SCHEMBL6172497 0.87 IGF1R (0.37) IGF1RMAPTARTRPV3KMT2A
SCHEMBL6175269 0.86 MAPT (0.40) IGF1RMAPTARTRPV3KMT2A
SCHEMBL6174371 0.86 IGF1R (0.44) IGF1RMAPT
SCHEMBL6175494 0.84 IGF1R (0.35) IGF1RARTRPV3KMT2AHRH4
SCHEMBL6203204 0.83 IGF1R (0.40) IGF1RMAPTARTRPV3KMT2A
SCHEMBL6175019 0.83 DPP4 (0.37) IGF1RCHRNA7ARTRPV3KMT2A
SCHEMBL6175022 0.83 IGF1R (0.40) IGF1RARTRPV3KMT2AHRH4
SCHEMBL6175941 0.82 PTGS2 (0.39) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed